81 related articles for article (PubMed ID: 14505730)
1. 2,4-Dicarboxy-pyrroles as selective non-competitive mGluR1 antagonists: an exploration of the role of the pyrrolic scaffold.
Micheli F; Di Fabio R; Cavanni P; Donati D; Faedo S; Gehanne S; Maffeis M; Marchioro C; Sabbatini FM; Tarzia G; Tranquillini ME; Viziano M
Farmaco; 2003 Oct; 58(10):1005-9. PubMed ID: 14505730
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and pharmacological characterisation of 2,4-dicarboxy-pyrroles as selective non-competitive mGluR1 antagonists.
Micheli F; Fabio RD; Cavanni P; Rimland JM; Capelli AM; Chiamulera C; Corsi M; Corti C; Donati D; Feriani A; Ferraguti F; Maffeis M; Missio A; Ratti E; Paio A; Pachera R; Quartaroli M; Reggiani A; Sabbatini FM; Trist DG; Ugolini A; Vitulli G
Bioorg Med Chem; 2003 Jan; 11(2):171-83. PubMed ID: 12470711
[TBL] [Abstract][Full Text] [Related]
3. 2,4-Dicarboxy-pyrroles as selective non-competitive mGluR1 antagonists: further characterization of 3,5-dimethyl pyrrole-2,4-dicarboxylic acid 2-propyl ester 4-(1,2,2-trimethyl-propyl) ester and structure-activity relationships.
Micheli F; Di Fabio R; Bordi F; Cavallini P; Cavanni P; Donati D; Faedo S; Maffeis M; Sabbatini FM; Tarzia G; Tranquillini ME
Bioorg Med Chem Lett; 2003 Jul; 13(13):2113-8. PubMed ID: 12798316
[TBL] [Abstract][Full Text] [Related]
4. 3-Methyl pyrrole-2,4-dicarboxylic acid 2-propyl ester 4-(1,2,2-trimethyl-propyl) ester: an exploration of the C-2 position. Part I.
Micheli F; Di Fabio R; Benedetti R; Capelli AM; Cavallini P; Cavanni P; Davalli S; Donati D; Feriani A; Gehanne S; Hamdan M; Maffeis M; Sabbatini FM; Tranquillini ME; Viziano MV
Farmaco; 2004 Mar; 59(3):175-83. PubMed ID: 14987980
[TBL] [Abstract][Full Text] [Related]
5. From pyrroles to pyrrolo[1,2-a]pyrazinones: a new class of mGluR1 antagonists.
Micheli F; Cavanni P; Di Fabio R; Marchioro C; Donati D; Faedo S; Maffeis M; Sabbatini FM; Tranquillini ME
Bioorg Med Chem Lett; 2006 Mar; 16(5):1342-5. PubMed ID: 16337118
[TBL] [Abstract][Full Text] [Related]
6. From pyrroles to 1-oxo-2,3,4,9-tetrahydro-1H-beta-carbolines: a new class of orally bioavailable mGluR1 antagonists.
Di Fabio R; Micheli F; Alvaro G; Cavanni P; Donati D; Gagliardi T; Fontana G; Giovannini R; Maffeis M; Mingardi A; Tranquillini ME; Vitulli G
Bioorg Med Chem Lett; 2007 Apr; 17(8):2254-9. PubMed ID: 17276684
[TBL] [Abstract][Full Text] [Related]
7. Stereoselective synthesis and preliminary evaluation of (+)- and (-)-3-methyl-5-carboxy-thien-2-yl-glycine (3-MATIDA): identification of (+)-3-MATIDA as a novel mGluR1 competitive antagonist.
Costantino G; Marinozzi M; Camaioni E; Natalini B; Sarichelou I; Micheli F; Cavanni P; Faedo S; Noe C; Moroni F; Pellicciari R
Farmaco; 2004 Feb; 59(2):93-9. PubMed ID: 14871500
[TBL] [Abstract][Full Text] [Related]
8. 13C bis-labeled pyrroles: a tool for the identification of the rat metabolism of 3-methyl pyrrole-2,4-dicarboxylic acid 2-propyl ester 4-(1,2,2-trimethyl-propyl) ester.
Micheli F; Cavanni P; Di Fabio R; Donati D; Hamdan M; Provera S; Tranquillini ME; Vitulli G
Bioorg Med Chem Lett; 2007 Feb; 17(4):969-73. PubMed ID: 17157010
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationship of triazafluorenone derivatives as potent and selective mGluR1 antagonists.
Zheng GZ; Bhatia P; Daanen J; Kolasa T; Patel M; Latshaw S; El Kouhen OF; Chang R; Uchic ME; Miller L; Nakane M; Lehto SG; Honore MP; Moreland RB; Brioni JD; Stewart AO
J Med Chem; 2005 Nov; 48(23):7374-88. PubMed ID: 16279797
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationships of novel non-competitive mGluR1 antagonists: a potential treatment for chronic pain.
Owen DR; Dodd PG; Gayton S; Greener BS; Harbottle GW; Mantell SJ; Maw GN; Osborne SA; Rees H; Ringer TJ; Rodriguez-Lens M; Smith GF
Bioorg Med Chem Lett; 2007 Jan; 17(2):486-90. PubMed ID: 17064898
[TBL] [Abstract][Full Text] [Related]
11. Dopamine/serotonin receptor ligands. 10: SAR Studies on azecine-type dopamine receptor ligands by functional screening at human cloned D1, D2L, and D5 receptors with a microplate reader based calcium assay lead to a novel potent D1/D5 selective antagonist.
Hoefgen B; Decker M; Mohr P; Schramm AM; Rostom SA; El-Subbagh H; Schweikert PM; Rudolf DR; Kassack MU; Lehmann J
J Med Chem; 2006 Jan; 49(2):760-9. PubMed ID: 16420061
[TBL] [Abstract][Full Text] [Related]
12. Discovery of orally efficacious tetracyclic metabotropic glutamate receptor 1 (mGluR1) antagonists for the treatment of chronic pain.
Wu WL; Burnett DA; Domalski M; Greenlee WJ; Li C; Bertorelli R; Fredduzzi S; Lozza G; Veltri A; Reggiani A
J Med Chem; 2007 Nov; 50(23):5550-3. PubMed ID: 17929793
[TBL] [Abstract][Full Text] [Related]
13. [Research progress of selective mGluR1 antagonists].
Yang YL; Sun W; Peng C; Zhang XY; Yang XH
Yao Xue Xue Bao; 2011 Oct; 46(10):1167-72. PubMed ID: 22242445
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and characterization of 1,3-dihydro-benzo[b][1,4]diazepin-2-one derivatives: Part 3. New potent non-competitive metabotropic glutamate receptor 2/3 antagonists.
Woltering TJ; Wichmann J; Goetschi E; Adam G; Kew JN; Knoflach F; Ballard TM; Huwyler J; Mutel V; Gatti S
Bioorg Med Chem Lett; 2008 Apr; 18(8):2725-9. PubMed ID: 18374569
[TBL] [Abstract][Full Text] [Related]
15. Novel thienopyrimidinones as mGluR1 antagonists.
Kim Y; Kim J; Kim S; Ki Y; Seo SH; Tae J; Ko MK; Jang HS; Lim EJ; Song C; Cho Y; Koh HY; Chong Y; Choo IH; Keum G; Min SJ; Choo H
Eur J Med Chem; 2014 Oct; 85():629-37. PubMed ID: 25127154
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization of a new, orally active and potent allosteric metabotropic glutamate receptor 1 antagonist, 4-[1-(2-fluoropyridin-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide (FTIDC).
Suzuki G; Kimura T; Satow A; Kaneko N; Fukuda J; Hikichi H; Sakai N; Maehara S; Kawagoe-Takaki H; Hata M; Azuma T; Ito S; Kawamoto H; Ohta H
J Pharmacol Exp Ther; 2007 Jun; 321(3):1144-53. PubMed ID: 17360958
[TBL] [Abstract][Full Text] [Related]
17. Potent antihyperalgesic activity without tolerance produced by glycine site antagonist of N-methyl-D-aspartate receptor GV196771A.
Quartaroli M; Carignani C; Dal Forno G; Mugnaini M; Ugolini A; Arban R; Bettelini L; Maraia G; Belardetti F; Reggiani A; Trist DG; Ratti E; Di Fabio R; Corsi M
J Pharmacol Exp Ther; 1999 Jul; 290(1):158-69. PubMed ID: 10381772
[TBL] [Abstract][Full Text] [Related]
18. Spinal antinociception evoked by the triterpene 3beta, 6beta, 16beta-trihydroxylup-20(29)-ene in mice: evidence for the involvement of the glutamatergic system via NMDA and metabotropic glutamate receptors.
Longhi-Balbinot DT; Pietrovski EF; Gadotti VM; Martins DF; Facundo VA; Santos AR
Eur J Pharmacol; 2009 Nov; 623(1-3):30-6. PubMed ID: 19765585
[TBL] [Abstract][Full Text] [Related]
19. Phenylethynyl-pyrrolo[1,2-a]pyrazine: a new potent and selective tool in the mGluR5 antagonists arena.
Micheli F; Bertani B; Bozzoli A; Crippa L; Cavanni P; Di Fabio R; Donati D; Marzorati P; Merlo G; Paio A; Perugini L; Zarantonello P
Bioorg Med Chem Lett; 2008 Mar; 18(6):1804-9. PubMed ID: 18304814
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and SAR development of novel mGluR1 antagonists for the treatment of chronic pain.
Brumfield S; Korakas P; Silverman LS; Tulshian D; Matasi JJ; Qiang L; Bennett CE; Burnett DA; Greenlee WJ; Knutson CE; Wu WL; Sasikumar TK; Domalski M; Bertorelli R; Grilli M; Lozza G; Reggiani A; Li C
Bioorg Med Chem Lett; 2012 Dec; 22(23):7223-6. PubMed ID: 23084894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
